查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592003

体外诊断药品包装市场：按产品、最终用户划分 - 全球预测 2025-2030 年

In-Vitro Diagnostics Packaging Market by Product (Bottles, Closures, Tubes), End User (Academic Institutes, Clinical Laboratories, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体外诊断包装市场规模为72.4亿美元，预计2024年将达77亿美元，复合年增长率为6.75%，预计到2030年将达到114.4亿美元。

体外诊断（IVD）包装市场是指体外诊断领域产品所需的专业包装解决方案，例如用于诊断和监测健康状况的试剂、仪器和检测套组。范围和定义涵盖了确保诊断组件（例如管瓶、管子、瓶子和瓶盖）的安全性、稳定性和无菌性的包装类型。严格的监管标准推动了对坚固 IVD 包装的需求，这些标准确保产品完整性、防止污染并满足运输温度敏感诊断的复杂物流需求。从应用来看，这些包装解决方案对于医院、实验室和诊所至关重要，最终用途包括病理实验室、研究机构和学术部门。关键的成长要素包括慢性病和感染疾病的流行、对就地检验的需求不断增加以及个人化医疗的进步。机会比比皆是，包括向永续和环保包装材料的转变，以及对增强产品追踪和用户参与度的智慧包装等创新解决方案的需求不断增长。然而，严格的监管要求和与创新封装技术相关的高成本构成了重大的市场挑战。此外，随着世界各地医疗保健系统的价格压力持续增加，对具有成本效益的包装解决方案的需求仍然是关键限制因素。潜在的创新领域包括开发结合物联网和 RFID 技术的智慧包装，以提高供应链效率、增强防篡改功能以及符合全球永续性目标的材料可回收性和提高的生物分解性。为了在这个充满活力的市场中取得成功，参与者必须专注于策略联盟和持续研发，以开发适应体外诊断行业不断变化的需求的适应性强且合规的包装解决方案。彻底的市场研究提供竞争考察，让您随时了解客户偏好和技术进步，并帮助您适应创新主导但高度监管的市场的本质。

主要市场统计
基准年[2023] 72.4亿美元
预测年份 [2024] 77亿美元
预测年份 [2030] 114.4亿美元
复合年增长率（%） 6.75%

市场动态：快速发展的体外诊断包装市场的关键市场洞察

供需的动态交互作用正在改变体外诊断包装市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和感染疾病的盛行率
    • 就地检验的成长趋势
    • 个性化医疗的趋势
  • 市场限制因素
    • 体外诊断药物包装的製造成本高
  • 市场机会
    • 体外诊断智慧包装简介
    • 持续研究和开发永续体外诊断包装的生产
  • 市场挑战
    • 体外诊断包装设计的复杂性

波特五力：驾驭体外诊断包装市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体外诊断药品包装市场的外部影响

外部宏观环境因素在塑造体外诊断药物包装市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解体外诊断药物包装市场的竞争状况

对体外诊断药品包装市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体外诊断药物包装市场供应商绩效评估

FPNV 定位矩阵是评估体外诊断药品包装市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了体外诊断药品包装市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，体外诊断药品包装市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病及感染疾病率增加
      • 就地检验的成长趋势
      • 个性化医疗方法的趋势
    • 抑制因素
      • 体外诊断包装的生产成本较高。
    • 机会
      • 体外诊断智慧包装简介
      • 持续研究和开发永续的体外诊断包装製造
    • 任务
      • 体外诊断包装设计的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外诊断药物包装市场：副产品

  • 瓶子
  • 关闭
  • 管子
  • 管瓶

第七章体外诊断药品包装市场：依最终用户分类

  • 学术机构
  • 临床实验室
  • 医院

第八章 北美、南美洲体外诊断药物包装市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太体外诊断药品包装市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲体外诊断药物包装市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amcor PLC
  • APTARGROUP, INC.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • DWK Life Sciences LLC
  • James Alexander Corporation
  • Narang Medical Limited
  • Oliver-Tolas Healthcare Packaging BV
  • PerkinElmer Inc.
  • PMMI Media Group
  • QIAGEN NV
  • Siemens AG
  • SONIC PACKAGING
  • Thermofisher Scientific Inc.
  • VITLAB GmbH
Product Code: MRR-F6513A06BD97

The In-Vitro Diagnostics Packaging Market was valued at USD 7.24 billion in 2023, expected to reach USD 7.70 billion in 2024, and is projected to grow at a CAGR of 6.75%, to USD 11.44 billion by 2030.

The In-Vitro Diagnostics (IVD) Packaging market refers to the specialized packaging solutions required for products in the in-vitro diagnostics sector, including reagents, instruments, and testing kits used in the diagnosis and monitoring of health conditions. Scope and definition cover packaging types such as vials, tubes, bottles, and closures that ensure the safety, stability, and sterility of diagnostic components. The necessity for robust IVD packaging is driven by the strict regulatory standards ensuring product integrity, preventing contamination, and addressing the complex logistics needs of transporting temperature-sensitive diagnostics. Application-wise, these packaging solutions are pivotal across hospitals, laboratories, and clinics, while the end-use scope spans pathology labs, research institutes, and academic sectors. Key growth influencers include the increasing prevalence of chronic and infectious diseases, escalated demand for point-of-care testing, and advancements in personalized medicine. Opportunities abound with the shift toward sustainable and eco-friendly packaging materials, and increased demand for innovative solutions like smart packaging that enhances product tracking and user engagement. However, stringent regulatory requirements and high costs associated with innovative packaging technologies pose significant market challenges. Furthermore, the need for cost-effective packaging solutions remains a critical limitation as pricing pressures continue to rise across healthcare systems globally. Potential areas of innovation include developing intelligent packaging that incorporates IoT and RFID technologies for improved supply chain efficiency, enhancing tamper-evidence features, and increasing the recyclability and biodegradability of materials to align with global sustainability goals. To thrive in this dynamic market, players should focus on strategic collaborations and continuous R&D to offer adaptable and compliant packaging solutions tailored to the evolving needs of the IVD industry. Conducting in-depth market research would yield competitive insights and keep businesses abreast of customer preferences and technological advancements, addressing the nature of the market that is innovation-driven but heavily regulated.

KEY MARKET STATISTICS
Base Year [2023] USD 7.24 billion
Estimated Year [2024] USD 7.70 billion
Forecast Year [2030] USD 11.44 billion
CAGR (%) 6.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Packaging Market

The In-Vitro Diagnostics Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic and infectious diseases
    • Rising trend of point-of-care testing
    • Inclination toward personalized medicine approach
  • Market Restraints
    • High cost of production of in-vitro diagnostic packaging
  • Market Opportunities
    • Introduction of smart packaging for in-vitro diagnostics
    • Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
  • Market Challenges
    • Complexity in designing in-vitro diagnostic packaging

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Packaging Market

A detailed market share analysis in the In-Vitro Diagnostics Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Packaging Market

A strategic analysis of the In-Vitro Diagnostics Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, APTARGROUP, INC., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, DWK Life Sciences GmbH, DWK Life Sciences LLC, James Alexander Corporation, Narang Medical Limited, Oliver-Tolas Healthcare Packaging B.V., PerkinElmer Inc., PMMI Media Group, QIAGEN N.V., Siemens AG, SONIC PACKAGING, Thermofisher Scientific Inc., and VITLAB GmbH.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bottles, Closures, Tubes, and Vials.
  • Based on End User, market is studied across Academic Institutes, Clinical Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising trend of point-of-care testing
      • 5.1.1.3. Inclination toward personalized medicine approach
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of in-vitro diagnostic packaging
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart packaging for in-vitro diagnostics
      • 5.1.3.2. Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in designing in-vitro diagnostic packaging
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Bottles
  • 6.3. Closures
  • 6.4. Tubes
  • 6.5. Vials

7. In-Vitro Diagnostics Packaging Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Institutes
  • 7.3. Clinical Laboratories
  • 7.4. Hospitals

8. Americas In-Vitro Diagnostics Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor PLC
  • 2. APTARGROUP, INC.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Corning Incorporated
  • 6. DWK Life Sciences GmbH
  • 7. DWK Life Sciences LLC
  • 8. James Alexander Corporation
  • 9. Narang Medical Limited
  • 10. Oliver-Tolas Healthcare Packaging B.V.
  • 11. PerkinElmer Inc.
  • 12. PMMI Media Group
  • 13. QIAGEN N.V.
  • 14. Siemens AG
  • 15. SONIC PACKAGING
  • 16. Thermofisher Scientific Inc.
  • 17. VITLAB GmbH

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023